AbbVie to acquire cancer drug maker Pharmacyclics in $21bn deal

AbbVie to acquire cancer drug maker Pharmacyclics in $21bn deal

By Carrie Ann - Mar 05, 2015

US-based biopharmaceutical firm AbbVie announced Wednesday that it has agreed to acquire Pharmacyclics Inc for about $21...

Read More